<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Institute of Public Health</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/4B98F259-77FE-4FC0-9296-140C9C066977"><gtr:id>4B98F259-77FE-4FC0-9296-140C9C066977</gtr:id><gtr:firstName>John</gtr:firstName><gtr:surname>Danesh</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A82DCE4F-9E98-4ADC-8584-4A6B0553268F"><gtr:id>A82DCE4F-9E98-4ADC-8584-4A6B0553268F</gtr:id><gtr:firstName>Chris</gtr:firstName><gtr:otherNames>J</gtr:otherNames><gtr:surname>Packard</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D4875E5B-C2B2-4BB4-BA70-E1170A00D2A7"><gtr:id>D4875E5B-C2B2-4BB4-BA70-E1170A00D2A7</gtr:id><gtr:firstName>Simon</gtr:firstName><gtr:surname>Thompson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/C3A08924-3211-47F9-A709-DC28DAD85A96"><gtr:id>C3A08924-3211-47F9-A709-DC28DAD85A96</gtr:id><gtr:firstName>Rory</gtr:firstName><gtr:surname>Collins</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0501792"><gtr:id>402472E7-1DA8-4516-AE20-D2474FF36B1D</gtr:id><gtr:title>Triglycerides and cardiovascular disease: meta-analysis of individual data on 600 000 participants in 60 studies</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0501792</gtr:grantReference><gtr:abstractText>Triglycerides are specific fats that are increased in the blood of people who smoke, eat fatty foods and have high blood pressure. Widely available tests that can measure blood triglycerides concentrations are frequently used to help predict heart attack risk. Although dozens of long-term studies of triglycerides and heart attack risk have been conducted over the past 50 years, it is still uncertain whether measurement of these blood fats is actually worthwhile or whether they are likely to be causative of heart attacks. Individual studies have tended to be too small, and previous reviews of such studies have been insufficiently detailed to give clear results. To help provide much more reliable evidence about the relevance of triglycerides to heart disease, we will conduct detailed combined analyses of the available studies of triglycerides and future heart attack risk in a total of about 600 000 individuals from about 60 long-term studies. Previously, this approach helped clarify the evidence about other predictors of heart attack (such as blood pressure) and it should also do so for triglycerides.</gtr:abstractText><gtr:technicalSummary>Despite almost fifty years of epidemiological research, there is uncertainty about the relevance of triglycerides to coronary heart disease (CHD) in general populations. Individual studies have been too limited and previous reviews of such studies have been insufficiently detailed. We will conduct a meta-analysis of individual data on 600 000 participants from 60 studies, which have recorded a total of 25 000 incident cases of non-fatal myocardial infarction or coronary death. Such an analysis will reliably characterize several features of the association between triglycerides and CHD (and other major vascular and non-vascular outcomes) in appropriate detail and with precision, such as the magnitude of associations in different circumstances (e.g., in women and men, at different levels of triglycerides, at different ages, at different levels of known risk factors, at different levels of markers of insulin sensitivity [notably HDL]) after making appropriate allowances for within-person variability in triglycerides values and for possible confounding factors. These findings will contribute compelling evidence that will help to determine the potential usefulness of: (i) measurement of triglycerides in the prediction of CHD and (ii) strategies that lower triglycerides in cardiovascular disease prevention.</gtr:technicalSummary><gtr:fund><gtr:end>2009-11-05</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-11-06</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>370995</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Media interviews</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>6FB62636-E6E8-4396-92FC-8F5680329D2E</gtr:id><gtr:impact>Interviews with representatives of the media to discuss potential implications of findings from the most comprehensive scientific study to date investigating lipid measurements and cardiovascular risk.

Profiling of research by the BBC, Heart.org, Times of India, worldnews.com and several national newspapers.</gtr:impact><gtr:outcomeId>DA883B141AE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>463767</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomedical Research Centre grant - Cardiovascular Theme</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>A680E95F-3835-4CCA-BD42-C35F1D1D6762</gtr:id><gtr:outcomeId>56e0114e1eb3d4.38985030</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1365496</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Biomedical Research Centre grant - Population Science Theme</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>2C5D7E03-80A3-4FEC-ACD2-58216945E669</gtr:id><gtr:outcomeId>56e011946e7492.14348329</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>ERFC - major lipids</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>2D224072-923D-4047-948D-853C93B69003</gtr:id><gtr:impact>The ERFC paper on major lipids has been cited in the 2011 ESC / EAS Guidelines for the management of dyslipidaemias, in the 2012 ESC Guidelines, the 2011 American Association of Clinical Endocrinologists Medical Guidelines, and the 2011 AHA Statement on Triglycerides and cardiovascular disease. The ERFC publication on the causal relevance of triglyceride-related pathways to coronary disease has been cited in the following guidelines to support the rationale for diagnosis and treatment of hypertriglyceridaemia: the 2012 Endocrine Society Clinical Practice Guideline, the 2011 ESC / EAS Guidelines for the management of dyslipidaemias, and the 2011 AHA Statement on Triglycerides and cardiovascular disease.</gtr:impact><gtr:outcomeId>pow5KSQowc8</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A database has been created of harmonised individual participant data records from over 2 million individuals</gtr:description><gtr:id>DC5FAE86-3EE7-4AEA-ACAD-E21150BB3744</gtr:id><gtr:impact>Published article PMID: 19903920</gtr:impact><gtr:outcomeId>1F7779904B8</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Emerging Risk Factors Collaboration database</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19903920</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Several novel statistical methods have been developed to enable maximal exploitation of the Emerging Risk Factors Collaboration database.</gtr:description><gtr:id>06E9969F-EDE1-424B-900D-741811257247</gtr:id><gtr:impact>Publication of article PMID: 19903920</gtr:impact><gtr:outcomeId>66E24ECC48D</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Emerging Risk Factors Collaboration statistical methods</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://europepmc.org/abstract/MED/19903920</gtr:url></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>5D3191F5-B724-46CD-8126-EB8A1444871B</gtr:id><gtr:title>Major lipids, apolipoproteins, and risk of vascular disease.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00954130f581451305ebfe461866731f"><gtr:id>00954130f581451305ebfe461866731f</gtr:id><gtr:otherNames>Emerging Risk Factors Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>56e0349244c728.70342491</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43455817-BCB8-46A6-BD5E-074D48E6311B</gtr:id><gtr:title>Lipid-related markers and cardiovascular disease prediction.</gtr:title><gtr:parentPublicationTitle>JAMA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00954130f581451305ebfe461866731f"><gtr:id>00954130f581451305ebfe461866731f</gtr:id><gtr:otherNames>Emerging Risk Factors Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0098-7484</gtr:issn><gtr:outcomeId>56e033d5165947.26715493</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>805871E9-B949-4011-8049-01AA762AC167</gtr:id><gtr:title>The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.</gtr:title><gtr:parentPublicationTitle>European journal of epidemiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00954130f581451305ebfe461866731f"><gtr:id>00954130f581451305ebfe461866731f</gtr:id><gtr:otherNames>Emerging Risk Factors Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0393-2990</gtr:issn><gtr:outcomeId>56e1307890a512.13824808</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E288AB64-6AE6-472B-A26F-B25469809E9C</gtr:id><gtr:title>Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4832a811237e349a300010863ec47d33"><gtr:id>4832a811237e349a300010863ec47d33</gtr:id><gtr:otherNames>Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>56e133522e08a6.55511547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2677DEF5-B000-4E67-89C6-E16D3961DE4A</gtr:id><gtr:title>Triglycerides and coronary heart disease: have recent insights yielded conclusive answers?</gtr:title><gtr:parentPublicationTitle>Current opinion in lipidology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d776525670b71858c08415ca453b026"><gtr:id>1d776525670b71858c08415ca453b026</gtr:id><gtr:otherNames>Sarwar N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0957-9672</gtr:issn><gtr:outcomeId>56e13335b213d7.23377684</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9673E4D0-F017-4A03-AB5E-1C66B00B1DC0</gtr:id><gtr:title>Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.</gtr:title><gtr:parentPublicationTitle>Circulation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1d776525670b71858c08415ca453b026"><gtr:id>1d776525670b71858c08415ca453b026</gtr:id><gtr:otherNames>Sarwar N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0009-7322</gtr:issn><gtr:outcomeId>56e13016ed9497.72421485</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0501792</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>3BEA012A-C817-4067-8BE1-05331EBB5152</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.2  Evaluation of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>